Cetuximab was also used in HNSCC along with sunitinib (a multikinase inhibitor that blocked VEGFR and PDGFR) and irradiation in CAL33 cells growing as orthotopic xenografts in nude mice. The gene discussed is PDGFRB; the disease is head and neck squamous cell carcinoma.